Showing results (241-250 of 251) with videos related to

Sort By:
Pageof 26
ESMO Open|July 10, 2026
Antibody-drug conjugates in selected solid tumours: a position statement update based on findings from the third workshop held by the ETOP IBCSG Partners FoundationS Peters, M-L Meyer, F André, et al.
ESMO Open|December 3, 2025
Efficacy and safety of atezolizumab plus bevacizumab in MSI-like metastatic colorectal cancer: a multicenter, single-arm, phase II, open-label clinical trialE Elez, S Siena, A Sartore-Bianchi, et al.
ESMO Open|June 1, 2023
The management of hepatocellular carcinoma. Current expert opinion and recommendations derived from the 24th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2022M Ducreux, G K Abou-Alfa, T Bekaii-Saab, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 27, 2012
ESMO Consensus Guidelines for management of patients with colon and rectal cancer. a personalized approach to clinical decision makingH J Schmoll, E Van Cutsem, A Stein, et al.
Gut|April 15, 2000
Analysis of genetic and phenotypic heterogeneity in juvenile polyposisK Woodford-Richens, S Bevan, M Churchman, et al.
Gut|January 16, 2008
Guidelines for the clinical management of familial adenomatous polyposis (FAP)H F A Vasen, G Möslein, A Alonso, et al.
Gut|June 29, 2010
Peutz-Jeghers syndrome: a systematic review and recommendations for managementA D Beggs, A R Latchford, H F A Vasen, et al.
Familial Cancer|September 19, 2009
Recommendations to improve identification of hereditary and familial colorectal cancer in EuropeH F A Vasen, G Möslein, A Alonso, et al.
ESMO Open|August 15, 2022
PRECISION: the Belgian molecular profiling program of metastatic cancer for clinical decision and treatment assignmentJ Thouvenin, C Van Marcke, L Decoster, et al.
Nature Communications|July 6, 2021
Monocyte-driven atypical cytokine storm and aberrant neutrophil activation as key mediators of COVID-19 disease severityL Vanderbeke, P Van Mol, Y Van Herck, et al.
Pageof 26